Risk of prolapse and urinary complications in adult spina bifida patients with neurogenic acontractile detrusor using clean intermittent catheterization versus Valsalva voiding.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
01 2019
Historique:
received: 24 05 2018
accepted: 15 09 2018
pubmed: 13 10 2018
medline: 28 1 2020
entrez: 13 10 2018
Statut: ppublish

Résumé

To assess the relative risks of pelvic organ prolapse (POP) and urinary complications in adult spina bifida patients with neurogenic acontractile detrusor voiding with Valsalva versus those using clean-intermittent catheterization (CIC). We conducted a retrospective analysis including all spina bifida patients with neurogenic acontractile detrusor with a minimum follow-up of 12 months. Patients were then divided in two groups according to their bladder management: voiding with Valsalva versus CIC. The primary endpoint was any de novo or worsened rectal and/or pelvic organ prolapse (POP) diagnosed during follow-up. The secondary outcome was urinary complications defined as febrile urinary tract infections (UTI) and/or urolithiasis and/or renal failure. Fifty-five patients (50.9% were males) met the inclusion/exclusion criteria: 28 voiding with Valsalva and 27 performing CIC. At baseline, the rates of vaginal prolapse (44.4% vs 50%; P = 0.99), and rectal prolapse/intussusception (25.9% vs 21.4%; P = 0.76) were similar in both groups. After a median follow-up of 80.6 and 65.6 months, respectively (P = 0.29), the rate of de novo or worsened rectal prolapse/intussusception was higher in the Valsalva voiding group than in the CIC group (32.1% vs 3.7%; P = 0.01). De novo or worsened vaginal prolapses were also more common in the Valsalva voiding group, but it did not reach statistical significance (33.3% vs 11.1%; P = 0.29). Valsalva voiding might be harmful in adult spina bifida patients with neurogenic acontractile detrusor as it may increase the risk of rectal prolapse/intussusception. Overall, the prevalence of POP and rectal prolapse was high in both groups.

Identifiants

pubmed: 30311685
doi: 10.1002/nau.23844
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

269-277

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Mehdi El Akri (M)

Service d'urologie, CHU Rennes, Rennes, France.

Charlène Brochard (C)

Service de Gastro-Entérologie, CHU Rennes, Rennes, France.
Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.
Equipe Thématique INPHY CIC 1414 et INSERM UMR 991, CHU Rennes, Rennes, France.

Juliette Hascoet (J)

Service d'urologie, CHU Rennes, Rennes, France.
Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.
Equipe Thématique INPHY CIC 1414 et INSERM UMR 991, CHU Rennes, Rennes, France.

Magali Jezequel (M)

Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.

Quentin Alimi (Q)

Service d'urologie, CHU Rennes, Rennes, France.
Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.

Zine-Eddine Khene (ZE)

Service d'urologie, CHU Rennes, Rennes, France.

Claire Richard (C)

Service d'urologie, CHU Rennes, Rennes, France.

Isabelle Bonan (I)

Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.
Service de Médecine Physique et Réadaptation, CHU Rennes, Rennes, France.

Jacques Kerdraon (J)

Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.
Centre de Rééducation de Kerpape, Ploemeur, France.

Xavier Gamé (X)

Département d'Urologie, Transplantation Rénale et Andrologie, CHU Rangueil, Toulouse, France.

Andrea Manunta (A)

Service d'urologie, CHU Rennes, Rennes, France.
Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.

Laurent Siproudhis (L)

Service de Gastro-Entérologie, CHU Rennes, Rennes, France.
Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.
Equipe Thématique INPHY CIC 1414 et INSERM UMR 991, CHU Rennes, Rennes, France.

Benoit Peyronnet (B)

Service d'urologie, CHU Rennes, Rennes, France.
Centre de Référence Spina Bifida, CHU Rennes, Rennes, France.
Equipe Thématique INPHY CIC 1414 et INSERM UMR 991, CHU Rennes, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH